1191268-97-9 Usage
Uses
Used in Pharmaceutical Industry:
C23H29ClOSi is used as an intermediate in the synthesis of Eribulin (E615203) for its role in the development of anticancer drugs. Eribulin is a microtubule dynamics inhibitor that has been shown to be effective against various types of cancer, including solid malignancies. The compound's unique structure allows it to be a crucial component in the synthesis process, contributing to the overall effectiveness of the final drug product.
Used in Cancer Treatment:
C23H29ClOSi is used as a key component in the development of Eribulin, an anticancer agent that targets microtubule dynamics. This disruption in microtubule dynamics leads to the inhibition of cell division and ultimately results in the death of cancer cells. Eribulin has been found to be effective against a range of solid malignancies, making C23H29ClOSi an essential part of the fight against cancer.
Check Digit Verification of cas no
The CAS Registry Mumber 1191268-97-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,1,2,6 and 8 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1191268-97:
(9*1)+(8*1)+(7*9)+(6*1)+(5*2)+(4*6)+(3*8)+(2*9)+(1*7)=169
169 % 10 = 9
So 1191268-97-9 is a valid CAS Registry Number.
1191268-97-9Relevant articles and documents
Chemoenzymatic process for the preparation of (S)-7-((tert-butyldiphenylsilyl)oxy)hept-1-yn-4-ol in a continuous packed-bed reactor, a key intermediate for eribulin synthesis
Basetty, Shalini,Chandrasekhar, Srivari,Ghosh, Subhash,Krishna, Avula Shiva,Kumaraguru, Thenkrishnan,Mainkar, Prathama S.,Nasam, Rajesh,Pabbaraja, Srihari,Ralte, Samuel L.,Reddy, Chada Raji,Sudhakar, Gangarajula
, p. 2657 - 2664 (2020/12/29)
A practical chemoenzymatic process has been developed for the preparation of optically pure (S)-7-((tertbutyldiphenylsilyl) oxy)hept-1-yn-4-ol, (S)-4. This was prepared via enantioselective acylation of racemic homopropargylic alcohol (+/-)-4 catalyzed by
Catalytic enantioselective Cr-Mediated propargylation: application to halichondrin synthesis
Liu, Songbai,Kim, Joseph T.,Dong, Cheng-Guo,Kishi, Yoshito
supporting information; experimental part, p. 4520 - 4523 (2009/12/08)
A catalytic enantioselective propargylation In the presence of 10 mol % of Cr catalyst prepared from Cr(III) bromide and (R)-sulfonamide E furnishes homopropargyl alcohol 8 In 78% yield with 90% ee. Coupled with the workup based on Amano-llpase, this meth